UnitedHealth Group (UNH) PT Raised to $295.00 at Oppenheimer
UnitedHealth Group (NYSE:UNH) had its price target increased by Oppenheimer from $276.00 to $295.00 in a research report sent to investors on Wednesday morning, The Fly reports. They currently have an outperform rating on the healthcare conglomerate’s stock. Oppenheimer also issued estimates for UnitedHealth Group’s Q4 2018 earnings at $3.19 EPS, FY2018 earnings at $12.79 EPS, Q1 2019 earnings at $3.41 EPS, Q2 2019 earnings at $3.56 EPS, Q3 2019 earnings at $3.82 EPS, Q4 2019 earnings at $3.70 EPS and FY2019 earnings at $14.49 EPS.
A number of other equities analysts also recently weighed in on UNH. Zacks Investment Research downgraded shares of UnitedHealth Group from a buy rating to a hold rating in a research note on Tuesday, June 19th. Cantor Fitzgerald reaffirmed a buy rating and issued a $300.00 target price on shares of UnitedHealth Group in a research note on Thursday, July 5th. BMO Capital Markets boosted their target price on shares of UnitedHealth Group from $285.00 to $300.00 and gave the stock a positive rating in a research note on Thursday, June 21st. Royal Bank of Canada boosted their target price on shares of UnitedHealth Group to $308.00 and gave the stock an outperform rating in a research note on Wednesday. Finally, Piper Jaffray Companies boosted their target price on shares of UnitedHealth Group to $300.00 and gave the stock an overweight rating in a research note on Wednesday. One equities research analyst has rated the stock with a hold rating, twenty-three have issued a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of Buy and an average target price of $289.41.
Shares of NYSE UNH opened at $265.30 on Wednesday. UnitedHealth Group has a 1-year low of $203.69 and a 1-year high of $272.81. The stock has a market capitalization of $257.27 billion, a price-to-earnings ratio of 26.35, a P/E/G ratio of 1.58 and a beta of 0.73. The company has a quick ratio of 0.75, a current ratio of 0.69 and a debt-to-equity ratio of 0.61.
In related news, CEO Steven H. Nelson sold 26,033 shares of the business’s stock in a transaction that occurred on Friday, September 7th. The shares were sold at an average price of $270.65, for a total transaction of $7,045,831.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director William C. Ballard, Jr. sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 8th. The shares were sold at an average price of $258.83, for a total transaction of $2,588,300.00. Following the transaction, the director now owns 77,172 shares of the company’s stock, valued at approximately $19,974,428.76. The disclosure for this sale can be found here. Over the last three months, insiders have sold 94,568 shares of company stock valued at $24,950,027. 0.87% of the stock is currently owned by insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. WoodTrust Financial Corp grew its holdings in UnitedHealth Group by 2.5% during the third quarter. WoodTrust Financial Corp now owns 7,823 shares of the healthcare conglomerate’s stock valued at $2,081,000 after purchasing an additional 189 shares during the period. Advisors Capital Management LLC grew its holdings in UnitedHealth Group by 15.2% during the third quarter. Advisors Capital Management LLC now owns 1,437 shares of the healthcare conglomerate’s stock valued at $382,000 after purchasing an additional 190 shares during the period. Chicago Partners Investment Group LLC grew its holdings in UnitedHealth Group by 26.5% during the second quarter. Chicago Partners Investment Group LLC now owns 920 shares of the healthcare conglomerate’s stock valued at $226,000 after purchasing an additional 193 shares during the period. Highland Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 0.5% in the third quarter. Highland Capital Management LLC now owns 36,128 shares of the healthcare conglomerate’s stock valued at $9,612,000 after buying an additional 194 shares during the period. Finally, OLD Mutual Customised Solutions Proprietary Ltd. boosted its holdings in shares of UnitedHealth Group by 1.2% in the second quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 17,096 shares of the healthcare conglomerate’s stock valued at $4,194,000 after buying an additional 200 shares during the period. Hedge funds and other institutional investors own 85.42% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Book Value Per Share in Stock Trading
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.